Collectively, in addition to modulation of Hsp70 and Hsp90, these data support the modulation of other chaperone families, such as Hsp40 and chaperonins, alone or in combination with Hsp70/90, as potential therapeutic strategies in HD. Here, DNAJB1 is linked to Huntington disease.